The EXCITE Trial: Predicting a clinically meaningful motor activity log outcome.
OBJECTIVE
This study determined which baseline clinical measurements best predicted a predefined clinically meaningful outcome on the Motor Activity Log (MAL) and developed a predictive multivariate model to determine outcome after 2 weeks of constraint-induced movement therapy (CIMT) and 12 months later using the database from participants in the Extremity Constraint Induced Therapy Evaluation (EXCITE) Trial.


METHODS
A clinically meaningful CIMT outcome was defined as achieving higher than 3 on the MAL Quality of Movement (QOM) scale. Predictive variables included baseline MAL, Wolf Motor Function Test (WMFT), the sensory and motor portion of the Fugl-Meyer Assessment (FMA), spasticity, visual perception, age, gender, type of stroke, concordance, and time after stroke. Significant predictors identified by univariate analysis were used to develop the multivariate model. Predictive equations were generated and odds ratios for predictors were calculated from the multivariate model.


RESULTS
Pretreatment motor function measured by MAL QOM, WMFT, and FMA were significantly associated with outcome immediately after CIMT. Pretreatment MAL QOM, WMFT, proprioception, and age were significantly associated with outcome after 12 months. Each unit of higher pretreatment MAL QOM score and each unit of faster pretreatment WMFT log mean time improved the probability of achieving a clinically meaningful outcome by 7 and 3 times at posttreatment, and 5 and 2 times after 12 months, respectively. Patients with impaired proprioception had a 20% probability of achieving a clinically meaningful outcome compared with those with intact proprioception.


CONCLUSIONS
Baseline clinical measures of motor and sensory function can be used to predict a clinically meaningful outcome after CIMT.
Park
Si-Woon
SW
Department of Stroke Rehabilitation, National Rehabilitation Center, Seoul, Korea. seanpark05@yahoo.co.kr
Wolf
Steven L
SL
Blanton
Sarah
S
Winstein
Carolee
C
Nichols-Larsen
Deborah S
DS
D000368:Aged; D005081:Exercise Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D008959:Models, Neurological; D009043:Motor Activity / Q000502:physiology*; D010291:Paresis / Q000209:etiology / Q000503:physiopathology* / Q000534:rehabilitation*; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012307:Risk Factors; D020521:Stroke / Q000150:complications / Q000503:physiopathology*; D000071939:Stroke Rehabilitation; D013997:Time Factors; D016896:Treatment Outcome; D034941:Upper Extremity
Stroke. 2004 Jun;35(6):1410-4
15087552
NeuroRehabilitation. 2006;21(2):97-105
16917157
Science. 1991 Jun 28;252(5014):1857-60
1843843
J Rehabil Res Dev. 1999 Jul;36(3):237-51
10659807
Stroke. 2001 Jul;32(7):1635-9
11441212
Neurorehabil Neural Repair. 2003 Sep;17(3):137-52
14503435
Neurology. 2006 Oct 10;67(7):1189-94
17030751
Stroke. 2005 Jun;36(6):1172-7
15890987
Physiother Res Int. 2000;5(1):1-18
10785907
Stroke. 2005 Nov;36(11):2493-6
16224078
Cogn Behav Neurol. 2006 Mar;19(1):48-54
16633019
Neurorehabil Neural Repair. 2005 Sep;19(3):238-49
16093415
Phys Ther. 2006 Jun;86(6):825-32
16737408
Scand J Rehabil Med. 1994 Sep;26(3):115-9
7801060
Arch Phys Med Rehabil. 1979 Jan;60(1):14-7
420565
JAMA. 2006 Nov 1;296(17):2095-104
17077374
Stroke. 1999 Nov;30(11):2369-75
10548673
Phys Ther. 2007 Feb;87(2):170-8
17244694
Neurologist. 2002 Nov;8(6):325-38
12801434